ArticleMediterranean journal of hematology and infectious diseases2022

Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients.

Nicola Sgherza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.